✦ LIBER ✦

Odanacatib, a cathepsin-K inhibitor for osteoporosis: A two-year study in postmenopausal women with low bone density

✍ Scribed by Henry G Bone; Michael R McClung; Christian Roux; Robert R Recker; John A Eisman; Nadia Verbruggen; Carolyn M Hustad; Carolyn DaSilva; Arthur C Santora; B Avery Ince

Book ID: 111485893
Publisher: American Society for Bone and Mineral Research
Year: 2009
Tongue: English
Weight: 276 KB
Volume: 25
Category: Article
ISSN: 0884-0431
DOI: 10.1359/jbmr.091035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Four-year results of a phase 2 study of

Four-year results of a phase 2 study of the cathepsin K inhibitor odanacatib in postmenopausal women with low bone mineral density: Effects on bone mineral density and bone turnover markers

✍ H. Resch; N. Binkley; H. Bone; J. Eisman; D. Hosking; B. Langdahl; M. McClung; I 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Treatment with the cathepsin K inhibitor

Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5 year results of a phase 2 trial

✍ B. Langdahl⁎; N. Binkley; H. Bone; N. Gilchrist; H. Resch; J. Rodriguez Portales 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Treatment with the cathepsin K inhibitor

Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5 year results of a phase 2 trial

✍ H. Resch; N. Binkley; H. Bone; J.A. Eisman; N. Gilchrist; B. Langdahl; J. Rodrig 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Two year results in a randomized, double

Two year results in a randomized, double-blind, placebo-controlled study of odanacatib (MK-822) in postmenopausal women with low bone mineral density

✍ J.A. Eisman; R.R. Recker; M. McClung; H. Bone; C. Roux; N. Verbruggen; C.M. Hust 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Odanacatib treatment in postmenopausal w

Odanacatib treatment in postmenopausal women with low bone mineral density: 24-month results

✍ M. McClung; J.A. Eisman; H.G. Bone; C. Roux; R.R. Recker; N. Verbruggen; C.M. Hu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Odanacatib in the treatment of postmenop

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study

✍ Langdahl, Bente; Binkley, Neil; Bone, Henry; Gilchrist, Nigel; Resch, Heinrich; 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 133 KB